Structure |
Chemical Name |
CAS |
MF |
|
Lenvatinib Impurity 2 |
2380197-90-8 |
C28H22ClN5O5 |
|
FeBuxostat Impurity 33 |
100118-38-5 |
C12H14O5 |
|
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl) |
1642630-12-3 |
C22H22N6O |
|
Latamoxef Impurity 1 |
75007-70-4 |
C19H20N6O7S |
|
Amlodipine iMpurity K |
1809326-44-0 |
C18H21ClN2O5 |
|
Cabozantinib impurity 4 |
95932-39-1 |
C11H15NO3 |
|
Rosuvastatin EP Impurity C |
1620823-61-1 |
C22H27FN3NaO6S |
|
6,7-bis(2-methoxyethoxy)-N-phenylquinazolin-4-amine |
1145671-52-8 |
C20H23N3O4 |
|
(3R,4R,5S)-ethyl 4-acetamido-5-amino-3-isopropoxycyclohex-1-enecarboxylate |
1052063-36-1 |
C14H24N2O4 |
|
4-(N-(tert-butyl)acetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate |
941296-96-4 |
C16H28N2O4 |
|
(2R,5S)-5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylic acid |
|
C8H8FN3O4S |
|
Amlodipine Impurity 10 |
2170104-51-3 |
C26H31ClN2O8S |
|
Clopidogrel Impurity 8 |
|
C15H14ClNO2S |
|
Nilotinib genotoxic impurity 3 |
915711-42-1 |
C19H17F3N4O |
|
Dapagliflozin Open Ring |
2100872-88-4 |
C21H27ClO7 |
|
Rortezide impurity |
|
|
|
Cabozantinib Impurity A |
|
|
|
Loxoprofen Impurity E |
|
|
|
(R)-4-Propylpyrrolidin-2-one |
930123-37-8 |
C7H13NO |
|
Rocuronium Bromide Intermediate B Impurity E-1 |
1190105-60-2 |
C29H48N2O3 |
|
4-Chloro-2-propylsulfanyl-pyrimidine |
1351990-36-7 |
C7H9ClN2S |
|
benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate |
1194550-67-8 |
C36H30Cl2N2O7S |
|
D-Proline, 1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]- |
119238-52-7 |
C9H15NO3S |
|
2,4(1H,3H)-Pyrimidinedione,5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2S-cis)- (9CI) |
145281-92-1 |
C8H9FN2O4S |
|
Cyclopentanecarboxylic acid, 1-[(1-oxopentyl)amino]- |
15026-80-9 |
C11H19NO3 |
|
L-Phenylalanine, N-L-leucyl-, methyl ester |
38155-18-9 |
C16H24N2O3 |
|
Ethanol, 2-[(2-chloroethyl)amino]- |
3890-98-0 |
C4H10ClNO |
|
Anthranilic acid, N-furfuryl-5-sulfamoyl- |
4818-85-3 |
C12H12N2O5S |
|
1,3-Benzodioxol-4-ol |
69393-72-2 |
C7H6O3 |
|
1H-Benzimidazole, 6-bromo-2-methyl-4-(phenylmethoxy)- |
774582-60-4 |
C15H13BrN2O |
|
2-Diethylamino-N-(2,5-dimethyl-phenyl)-acetamide |
857570-37-7 |
C14H22N2O |
|
(R)-1-BENZYL-3-N-BOC-AMINOPIPERIDINE |
216854-24-9 |
C17H26N2O2 |
|
(Z)-methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
1987887-92-2 |
C24H21N3O3 |
|
1-(prop-1-en-2-yl)-3-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzo[d]imidazol-2(3H)-one |
1971858-36-2 |
C23H25F3N4O |
|
2-(3-(methylamino)-1-(thiophen-2-yl)propyl)naphthalen-1-ol |
1033803-59-6 |
C18H19NOS |
|
Bendamustine Desmethyl Impurity |
41515-13-3 |
C15H19Cl2N3O2 |
|
(R)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine |
878757-08-5 |
C19H21NOS |
|
Capecitabine Impurity 10 |
|
|
|
Carfilzomib Impurity C |
|
|
|
Cefathiamidine Impurity 4 |
1418224-75-5 |
C10H11BrN2O5S |
|
Cefodizime Impurity 2 |
|
|
|
Choline Fenofibrate Impurity 1 |
2985-79-7 |
C13H9ClO2 |
|
DecitaBine Impurity 11 |
|
|
|
Isavuconazole Impurity 21 |
|
|
|
Isavuconazole Impurity 27 |
|
|
|
Istradefylline Impurity E |
|
|
|
Linagliptin Impurity 41 |
|
|
|
PalBociclib Impurity 17 |
|
|
|
PalBociclib Impurity 24 |
|
|
|
Posaconazole Impurity 12 |
|
|
|
Posaconazole Impurity 24 |
165115-78-6 |
C19H20F2O2 |
|
Sitagliptin Impurity 24 |
2349567-54-8 |
C15H19F2NO4 |
|
Tamoxifen EP Impurity H |
809285-09-4 |
C43H48N2O2 |
|
Tenofovir impurity Q |
|
|
|
Trelagliptin Impurity 20 |
1821520-42-6 |
C20H22FN5O3 |
|
Umeclidinium Impurity 3 |
869113-45-1 |
C29H32BrNO3 |
|
Vardenafil Impurity 7 |
448184-56-3 |
C21H26N6O7S |
|
Moxifloxacin Related Compound A (HCl salt form) |
151282-23-4 |
C20H22ClF2N3O3 |
|
8-Hydroxy Entecavir |
1795791-10-4 |
C12H15N5O4 |
|
1-Pyrrolidinecarboxylic acid, 4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4R)- |
1404559-22-3 |
C27H38N6O3S |
|
Ampicillin Impurity A |
|
|
|
Oxacillin Sodium Impurity B(EP) |
|
|
|
3,5-dichlorothiophene-2-carboxylic acid |
89166-94-9 |
C5H2Cl2O2S |
|
Brexpiprazole Impurity 2 |
2094559-58-5 |
C38H40N4O4S |
|
2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid |
80047-38-7 |
C12H10N2O3 |
|
Levofloxacin Impurity 7 |
1607796-83-7 |
C15H14FNO5 |
|
Moxifloxacin EP Impurity E HCl |
|
|
|
Pantoprazole Impurity 11 |
172282-50-7 |
C7H8F2N2O |
|
Solifenacin Related Compound 24 |
1682642-69-8 |
C15H23ClN2 |
|
Ticagrelor Related Compound 44 |
1431867-40-1 |
C8H12ClN3OS |
|
(trans)-2-(3,4-difluorophenyl)cyclopropanecarboxamide |
1006614-51-2 |
C10H9F2NO |
|
2-cyano-N-methyl-N-((3R,4R)-4-methyl piperidin-3-yl) Acetamide hydrochloride |
1640971-87-4 |
C10H18ClN3O |
|
6-methyl-N1-(4-methyl-6-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine |
|
C17H17N5 |
|
WPDCFRNNHUYQGW-IUXPMGMMSA-N |
1628639-06-4 |
C21H23NO4 |
|
tert-Butyl 2-((4S,6S)-6-(chloromethyl(02,2-1,3-dioxan-4-yl)acetate |
521974-00-5 |
C13H23ClO4 |
|
Cefadroxil Sulfoxide |
182290-77-3 |
C16H17N3O6S |
|
GSFIWDGFHNAUFU-UHFFFAOYSA-N |
2125702-80-7 |
C16H29N5O4 |
|
2,5-dichloro-N,N-dimethylbenzamide |
90526-01-5 |
C9H9Cl2NO |
|
Ibrutinib Impurity 9 |
2068022-09-1 |
C25H21D5N6O4 |
|
4-Chlor-3-hydroxybutyronitril |
105-33-9 |
C4H6ClNO |
|
(Z)-2-propylhept-2-enal |
95667-14-4 |
C10H18O |
|
(R)-3-AMINO-4-(2,4-DIFLUOROPHENYL)-BUTYRIC ACID-HCL |
1335470-16-0 |
C10H11F2NO2 |
|
4,4'-dichloro-3,3'-bis(4-ethoxybenzyl)-1,1'-biphenyl |
2176485-21-3 |
C30H28Cl2O2 |
|
N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide |
294852-91-8 |
C18H22N2O |
|
N6-propyl-3a,4,5,6,7,7a-hexahydrobenzo[d]thiazole-2,6-diamine |
1052691-22-1 |
C10H19N3S |
|
3-pentylisoindolin-1-one |
691863-84-0 |
C13H17NO |
|
(1R,3R)-2-acetyl-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro- 1H-pyrido[3,4-b]indole-3-carboxylate |
1598416-05-7 |
C22H20N2O5 |
|
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N- ((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl) methyl)-N-methylmethanamine hydrochloride |
|
C33H28ClF2N5O4S2 |
|
Labetalol EP impurity D |
32780-65-7 |
C9H13ClN2O3 |
|
ethyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate |
625115-53-9 |
C21H21FN8O2 |
|
2-[(4-CHLORO-2-NITROPHENYL)AMINO]-BENZOIC ACID |
60091-87-4 |
C13H9ClN2O4 |
|
Fulvestrant impurity I |
|
|
|
Emtricitabine |
61548-81-0 |
C11H22O3S |
|
tert-butyl 4-(3-nitropyridin-4-yl)piperazine-1-carboxylate |
608142-93-4 |
C14H20N4O4 |
|
4-BROMO-1-(TOLUENE-4-SULFONYL)-1,2,3,4-TETRAHYDROBENZO[B]AZEPIN-5-ONE |
29489-04-1 |
C17H16BrNO3S |
|
FEXOFENADINE, METHYL ESTER |
154825-96-4 |
C33H41NO4 |
|
Bendamustine Related Impurity 21 |
|
|
|
Bendamustine Related Impurity 8 |
|
|
|
Bortezomib Impurity 33 |
|
|
|
Moxifloxacin Impurity 31 |
|
|